Hua Lu

13.1k total citations · 1 hit paper
225 papers, 10.1k citations indexed

About

Hua Lu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hua Lu has authored 225 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Molecular Biology, 98 papers in Oncology and 36 papers in Cancer Research. Recurrent topics in Hua Lu's work include Cancer-related Molecular Pathways (89 papers), RNA modifications and cancer (45 papers) and Ubiquitin and proteasome pathways (39 papers). Hua Lu is often cited by papers focused on Cancer-related Molecular Pathways (89 papers), RNA modifications and cancer (45 papers) and Ubiquitin and proteasome pathways (39 papers). Hua Lu collaborates with scholars based in United States, China and South Korea. Hua Lu's co-authors include Mu‐Shui Dai, Shelya X. Zeng, Xiang Zhou, Yanping Zhang, Yetao Jin, Arnold J. Levine, Jun‐Ming Liao, Xiao‐Xin Sun, Peng Liao and Qian Hao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Hua Lu

216 papers receiving 9.9k citations

Hit Papers

Ribosomal proteins: funct... 2015 2026 2018 2022 2015 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hua Lu 7.4k 3.7k 1.5k 759 624 225 10.1k
Xinbin Chen 7.5k 1.0× 4.4k 1.2× 1.9k 1.3× 625 0.8× 977 1.6× 176 9.8k
Goberdhan P. Dimri 7.3k 1.0× 2.7k 0.7× 1.6k 1.0× 795 1.0× 445 0.7× 70 11.5k
Andrew H. Wyllie 5.6k 0.7× 3.2k 0.9× 1.8k 1.2× 549 0.7× 330 0.5× 57 9.2k
David K. Ann 5.0k 0.7× 1.9k 0.5× 2.0k 1.3× 641 0.8× 382 0.6× 171 8.3k
Dan A. Liebermann 7.4k 1.0× 3.9k 1.1× 1.8k 1.2× 745 1.0× 610 1.0× 138 11.1k
Sam W. Lee 5.0k 0.7× 2.3k 0.6× 1.1k 0.7× 906 1.2× 335 0.5× 93 7.1k
Olivia M. Pereira‐Smith 9.6k 1.3× 3.3k 0.9× 1.4k 0.9× 1.0k 1.4× 819 1.3× 108 14.3k
Eiji Hara 7.1k 0.9× 2.7k 0.7× 1.7k 1.1× 805 1.1× 360 0.6× 108 11.3k
Wenwei Hu 7.5k 1.0× 4.7k 1.3× 3.8k 2.5× 682 0.9× 605 1.0× 142 11.7k
John C. Reed 6.7k 0.9× 3.2k 0.9× 1.2k 0.8× 657 0.9× 620 1.0× 37 9.1k

Countries citing papers authored by Hua Lu

Since Specialization
Citations

This map shows the geographic impact of Hua Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua Lu more than expected).

Fields of papers citing papers by Hua Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hua Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua Lu. The network helps show where Hua Lu may publish in the future.

Co-authorship network of co-authors of Hua Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Hua Lu. A scholar is included among the top collaborators of Hua Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua Lu. Hua Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zuo, Bin, Zhanchao Wang, Hua Lu, & Hao Shen. (2025). Discovery of lipid metabolism-related diagnostic biomarkers and construction of diagnostic model in steroid-induced osteonecrosis of femoral head. Open Medicine. 20(1). 20251145–20251145.
2.
Lu, Hua, Yao Liu, Jiabei Wang, et al.. (2025). Micropeptide hSPAR regulates glutamine levels and suppresses mammary tumor growth via a TRIM21-P27KIP1-mTOR axis. The EMBO Journal. 44(5). 1414–1441. 3 indexed citations
3.
Nguyen, Daniel, et al.. (2025). Anti-cancer small-molecule Inauhzin-C confines its cytotoxicity to cancer cells by targeting GRP78. Biomedicine & Pharmacotherapy. 189. 118248–118248.
4.
Li, Qianpeng, Yang Zhang, Sicheng Luo, et al.. (2024). Identify Non-mutational p53 Functional Deficiency in Human Cancers. Genomics Proteomics & Bioinformatics. 22(5).
5.
Zhang, Yi, Xuemei Wang, Jun Lin, et al.. (2024). A microbial metabolite inhibits the HIF-2α-ceramide pathway to mediate the beneficial effects of time-restricted feeding on MASH. Cell Metabolism. 36(8). 1823–1838.e6. 26 indexed citations
6.
Lee, Hyemin, et al.. (2023). Extracellular and intracellular functions of coiled-coil domain containing 3. Journal of Molecular Cell Biology. 15(6). 1 indexed citations
7.
Zhang, Guangjian, et al.. (2023). Endovascular treatment of multiple intracranial aneurysms in patients with subarachnoid hemorrhage: one or multiple sessions?. Frontiers in Neurology. 14. 1196725–1196725. 3 indexed citations
8.
Wang, Jieqiong, Yajie Chen, Canhua Huang, et al.. (2021). Valosin-Containing Protein Stabilizes Mutant p53 to Promote Pancreatic Cancer Growth. Cancer Research. 81(15). 4041–4053. 13 indexed citations
9.
Lin, Chao, Nan Li, Zheng Li, et al.. (2020). Dual effects of thyroid hormone on neurons and neurogenesis in traumatic brain injury. Cell Death and Disease. 11(8). 671–671. 35 indexed citations
10.
Petrella, Teresa M., Pascal N. Tyrrell, Frances C. Wright, et al.. (2019). The clinical significance of indeterminate pulmonary nodules in melanoma patients at baseline and during follow-up chest CT. European Journal of Radiology Open. 6. 85–90. 10 indexed citations
11.
Shao, Jia, Linlin Xu, Limin Chen, et al.. (2017). Arl13b Promotes Gastric Tumorigenesis by Regulating Smo Trafficking and Activation of the Hedgehog Signaling Pathway. Cancer Research. 77(15). 4000–4013. 34 indexed citations
12.
Liao, Wenjuan, Hongbing Liu, Yiwei Zhang, et al.. (2017). Ccdc3: A New P63 Target Involved in Regulation Of Liver Lipid Metabolism. Scientific Reports. 7(1). 9020–9020. 19 indexed citations
13.
Nguyen, Daniel, Wenjuan Liao, Shelya X. Zeng, & Hua Lu. (2017). Reviving the guardian of the genome: Small molecule activators of p53. Pharmacology & Therapeutics. 178. 92–108. 58 indexed citations
14.
Lee, Kwan Young, et al.. (2017). Mdm2 mediates FMRP- and Gp1 mGluR-dependent protein translation and neural network activity. Human Molecular Genetics. 26(20). 3895–3908. 13 indexed citations
15.
Jung, Ji Hoon, Jun‐Ming Liao, Qi Zhang, et al.. (2015). Inauhzin(c) Inactivates c-Myc Independently of p53. Cancer Biology & Therapy. 16(3). 412–419. 13 indexed citations
16.
Zhang, Yiwei, Qi Zhang, Shelya X. Zeng, et al.. (2012). Inauhzin and Nutlin3 synergistically activate p53 and suppress tumor growth. Cancer Biology & Therapy. 13(10). 915–924. 24 indexed citations
17.
Yui, Naofumi, Hua Lu, Richard Bouley, & Dennis Brown. (2011). AQP2 is necessary for vasopressin- and forskolin-mediated filamentous actin depolymerization in renal epithelial cells. Biology Open. 1(2). 101–108. 31 indexed citations
18.
Ding, Yi, et al.. (2006). Interferon-Inducible Protein IFIXα1 Functions as a Negative Regulator of HDM2. Molecular and Cellular Biology. 26(5). 1979–1996. 36 indexed citations
19.
Dai, Mu‐Shui, Shelya X. Zeng, Yetao Jin, et al.. (2004). Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition. Molecular and Cellular Biology. 24(17). 7654–7668. 409 indexed citations
20.
Zeng, Xiaoya, Lihong Chen, Christine A. Jost, et al.. (1999). MDM2 Suppresses p73 Function without Promoting p73 Degradation. Molecular and Cellular Biology. 19(5). 3257–3266. 289 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026